Post-pandemic shifts in respiratory pathogens and peripheral immune correlates among hospitalized children with ALRTI: a retrospective molecular surveillance study in northern China, 2023–2024

Background Post-pandemic respiratory pathogen circulation has changed, but concurrent molecular and immune data remain limited. We examined pathogen trends and peripheral immune correlates in children hospitalized with acute lower respiratory tract infection (ALRTI) in northern China during 2023–2024. Methods This single-centre retrospective study included 604 hospitalization episodes. A 13-target multiplex nucleic-acid panel defined pathogen groups. Immunoglobulins, lymphocyte subsets and inflammatory markers were compared across monoinfection, mixed infection (≥2 pathogen categories) and panel-negative groups. Immune comparisons adjusted for age, sex and year using regression with cluster-robust standard errors for repeated admissions and false-discovery-rate correction. Annual trends were assessed using age-standardised rates and logistic regression adjusted for age, sex and calendar month. Results Among 601 complete-panel episodes, 528 (87.9%) had a detected pathogen. Mycoplasma pneumoniae predominated (43.4%), followed by rhinovirus (23.6%) and respiratory syncytial virus (RSV; 14.3%). M. pneumoniae detection increased from 32.4% in 2023 to 54.3% in 2024, while RSV decreased from 21.4% to 7.3% (both q < 0.001). Annual shifts persisted after age standardisation and covariate adjustment: adjusted odds ratios for 2024 vs. 2023 were 3.09 (95% CI, 1.94–4.94) for M. pneumoniae, 0.29 (0.16–0.53) for RSV and 0.13 (0.03–0.53) for influenza A. Mixed infection (21.5%) decreased with age (adjusted odds ratio per year, 0.92; 95% CI, 0.86–0.98). After adjustment and multiplicity correction, M. pneumoniae and mixed infections were associated with higher immunoglobulin M. Rhinovirus monoinfection was associated with lower total T-cell and CD8+ T-cell percentages and higher B-cell percentage; mixed infection was associated with lower total T-cell percentage. Cytokine analyses were exploratory because approximately 35% of episodes were tested. Conclusion Pathogen profiles shifted substantially between 2023 and 2024, supporting continued molecular surveillance and age-aware interpretation of immune measures. Because the panel did not cover typical bacterial pathogens, panel-negative episodes should not be equated with absence of infection.

Authors

Publication Details

Journal
Frontiers in Pediatrics
Published
2026-11-20
DOI
https://doi.org/10.3389/fped.2026.1980090
Primary Topic
Respiratory viral infections research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Post-pandemic shifts in respiratory pathogens and peripheral immune correlates among hospitalized children with ALRTI: a retrospective molecular surveillance study in northern China, 2023–2024

安淑华, Bo Niu, Jie Yuan, Wei Sun et al.
6 links
Frontiers in Pediatrics
Respiratory viral infections research
article

Post-pandemic shifts in respiratory pathogens and peripheral immune correlates among hospitalized children with ALRTI: a retrospective molecular surveillance study in northern China, 2023–2024

安淑华, Bo Niu, Jie Yuan, Wei Sun, Bojuan Zheng, Shengwang Ge
article en

Abstract

Background Post-pandemic respiratory pathogen circulation has changed, but concurrent molecular and immune data remain limited. We examined pathogen trends and peripheral immune correlates in children hospitalized with acute lower respiratory tract infection (ALRTI) in northern China during 2023–2024. Methods This single-centre retrospective study included 604 hospitalization episodes. A 13-target multiplex nucleic-acid panel defined pathogen groups. Immunoglobulins, lymphocyte subsets and inflammatory markers were compared across monoinfection, mixed infection (≥2 pathogen categories) and panel-negative groups. Immune comparisons adjusted for age, sex and year using regression with cluster-robust standard errors for repeated admissions and false-discovery-rate correction. Annual trends were assessed using age-standardised rates and logistic regression adjusted for age, sex and calendar month. Results Among 601 complete-panel episodes, 528 (87.9%) had a detected pathogen. Mycoplasma pneumoniae predominated (43.4%), followed by rhinovirus (23.6%) and respiratory syncytial virus (RSV; 14.3%). M. pneumoniae detection increased from 32.4% in 2023 to 54.3% in 2024, while RSV decreased from 21.4% to 7.3% (both q < 0.001). Annual shifts persisted after age standardisation and covariate adjustment: adjusted odds ratios for 2024 vs. 2023 were 3.09 (95% CI, 1.94–4.94) for M. pneumoniae, 0.29 (0.16–0.53) for RSV and 0.13 (0.03–0.53) for influenza A. Mixed infection (21.5%) decreased with age (adjusted odds ratio per year, 0.92; 95% CI, 0.86–0.98). After adjustment and multiplicity correction, M. pneumoniae and mixed infections were associated with higher immunoglobulin M. Rhinovirus monoinfection was associated with lower total T-cell and CD8+ T-cell percentages and higher B-cell percentage; mixed infection was associated with lower total T-cell percentage. Cytokine analyses were exploratory because approximately 35% of episodes were tested. Conclusion Pathogen profiles shifted substantially between 2023 and 2024, supporting continued molecular surveillance and age-aware interpretation of immune measures. Because the panel did not cover typical bacterial pathogens, panel-negative episodes should not be equated with absence of infection.

Frontiers in PediatricsVol. 14
Good health and well-being
Respiratory viral infections research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon